4.6 Review

Enteric hyperoxaluria: an important cause of end-stage kidney disease

Journal

NEPHROLOGY DIALYSIS TRANSPLANTATION
Volume 31, Issue 3, Pages 375-382

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/ndt/gfv005

Keywords

inflammatory bowel disease; kidney stones; oxalate; transplantation; urolithiasis

Funding

  1. Rare Kidney Stone Consortium part of the National Center for Advancing Translational Sciences (NCATS) Rare Diseases Clinical Research Network (RDCRN) [U54KD083908, DK83908]
  2. NCATS
  3. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Ask authors/readers for more resources

Hyperoxaluria is a frequent complication of inflammatory bowel diseases, ileal resection and Roux-en-Y gastric bypass and is well-known to cause nephrolithiasis and nephrocalcinosis. The associated prevalence of chronic kidney disease and end-stage kidney disease (ESKD) is less clear but may be more consequential than recognized. In this review, we highlight three cases of ESKD due to enteric hyperoxaluria following small bowel resections. We review current information on the pathophysiology, complications and treatment of this complex disease.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available